{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:12:41Z","timestamp":1792566761902,"version":"4.5.0"},"reference-count":34,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"237","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2014,5,21]]},"abstract":"<jats:p>FAK inhibitor treatment is effective against Merlin-negative mesothelioma tumors and preferentially targets cancer stem cells.<\/jats:p>","DOI":"10.1126\/scitranslmed.3008639","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T19:05:40Z","timestamp":1400699140000},"source":"Crossref","is-referenced-by-count":223,"title":["Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship"],"prefix":"10.1126","volume":"6","author":[{"given":"Irina M.","family":"Shapiro","sequence":"first","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihren N.","family":"Kolev","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Vidal","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwaraj","family":"Kadariya","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, PA 19111, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ring","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Wright","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Menges","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, PA 19111, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Padval","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I.","family":"McClatchey","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Center for Cancer Research and Department of Pathology, Harvard Medical School, Charlestown, MA 02129, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunli","family":"Xu","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Testa","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, PA 19111, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Pachter","sequence":"additional","affiliation":[{"name":"Verastem Inc., Cambridge, MA 02142, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1647"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3078"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1549"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.9346"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5155"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"A. Schultze W. Fiedler Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase. Anticancer Agents Med. Chem. 11 593\u2013599 (2011).","DOI":"10.2174\/187152011796817727"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0311-283"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm882"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2012.11"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20629"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1054603"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.10854"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.20209"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0494-RA"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385071-3.00006-X"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.12.054"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.02.054"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2062"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.9.10.11434"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0239"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0668"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2007.02.004"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01392-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209587"},{"key":"e_1_3_2_28_2","first-page":"3819","article-title":"N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.","volume":"61","author":"Li G.","year":"2001","unstructured":"Li G., Satyamoorthy K., Herlyn M., N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61, 3819\u20133825 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20393"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0891"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2010.10.008"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"abstract A249","DOI":"10.1158\/1535-7163.TARG-11-A249","article-title":"BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.","volume":"10","author":"Hirt U. A.","year":"2011","unstructured":"Hirt U. A., Braunger J., Schleicher M., Weyer-Czernilofsky U., Garin-Chesa P., Bister B., Stadtmueller H., Sapountzis I., Kraut N., Adolf G. R., BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer. Mol. Cancer Ther. 10, abstract A249 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/iub.303","article-title":"Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer.","volume":"62","author":"Guan J. L.","year":"2010","unstructured":"Guan J. L., Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 62, 268\u2013276 (2010).","journal-title":"IUBMB Life"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1351"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Soria J. C. Plummer R. Ranson M. Gan H. Arkenau H. T. Zalcman G. Blagden S. Evans T. R. J. Peddareddigari V. Mazumdar J. Murray S. Gibson D. Fleming R. A. Auger K. Millward M. Loss of the tumor suppressor merlin as a potential predictive biomarker of clinical activity for the oral focal adhesion kinase (FAK) inhibitor GSK2256098 in pts with recurrent mesothelioma paper presented at the 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Dublin Ireland 2012. http:\/\/www.ejcancer.com\/article\/S0959-8049(12)72407-3\/abstract","DOI":"10.1016\/S0959-8049(12)72407-3"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3008639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:59:12Z","timestamp":1705427952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3008639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":34,"journal-issue":{"issue":"237","published-print":{"date-parts":[[2014,5,21]]}},"alternative-id":["10.1126\/scitranslmed.3008639"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3008639","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}